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Abstract
Background
Due to a lack of reliable reference intervals (RIs) for Kenya, we set out to determine RIs for
40 common chemistry and immunoassay tests as part of the IFCC global RI project.
Methods
Apparently healthy adults aged 18–65 years were recruited according to a harmonized pro-
tocol and samples analyzed using Beckman-Coulter analyzers. Value assigned serum pan-
els were measured to standardize chemistry results. The need for partitioning reference
values by sex and age was based on between-subgroup differences expressed as standard
deviation ratio (SDR) or bias in lower or upper limits (LLs and ULs) of the RI. RIs were
derived using a parametric method with/without latent abnormal value exclusion (LAVE).
Results
Sex-specific RIs were required for uric acid, creatinine, total bilirubin (TBil), total cholesterol
(TC), ALT, AST, CK, GGT, transferrin, transferrin saturation (TfSat) and immunoglobulin-M.
Age-specific RIs were required for glucose and triglyceride for both sexes, and for urea,
magnesium, TC, HDL-cholesterol ratio, ALP, and ferritin for females. LAVE was effective in
optimizing RIs for AST, ALT, GGT iron-markers and CRP by reducing influence of latent
anemia and metabolic diseases. Thyroid profile RIs were derived after excluding volunteers
with anti-thyroid antibodies. Kenyan RIs were comparable to those of other countries partici-
pating in the global study with a few exceptions such as higher ULs for TBil and CRP.
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Conclusions
Kenyan RIs for major analytes were established using harmonized protocol from well-
defined reference individuals. Standardized RIs for chemistry analytes can be shared
across sub-Saharan African laboratories with similar ethnic and life-style profile.
Introduction
Reference intervals (RIs) are an integral part of laboratory reports as they assist clinicians in
interpretation of results. RIs should be population specific to ensure appropriate interpreta-
tion. Unfortunately, many clinical laboratories in sub-Saharan Africa (SSA) adopt RIs pro-
vided by manufacturers of laboratory reagents/equipment without verifying them as
recommended by the Clinical Laboratory Standards Institute (CLSI) [1]. This could result in
inaccurate interpretation of quantitative laboratory results leading to medical errors. Saathoff
et al carried out a study in the Mbeya region, south-western Tanzania and found marked dif-
ferences in RIs from the United States (US), Tanzania and other SSA countries. Overall, only
80.9% of reference values (RVs) for clinical chemistry tests from healthy individuals in Tanza-
nia would have been classified as normal as per the US RIs published by Kratz et al [2].
The International Federation of Clinical Chemistry (IFCC) under its Committee on Refer-
ence Intervals and Decision Limits (C-RIDL) has been carrying out a global RI study using a
protocol that harmonizes the pre-analytical, analytical and post-analytical study processes to
ensure ease of comparison of derived RIs across different regions, countries and ethnicities
[3].
An interim report of the global RI study comprising data from 12 countries identified
between ethnic group differences in both males and females for serum total protein (TP), albu-
min (Alb), total bilirubin (TBil), high density lipoprotein cholesterol (HDL-C), magnesium
(Mg), C-reactive protein (CRP), IgG, complement 3 (C3), vitamin B12, and folate. Females
were found to generally have more pronounced age-related changes in RVs. Ethnic differences
in BMI-related changes was also demonstrated. The only African country whose data were
included in the interim report was South Africa where comparisons between black South Afri-
cans and Caucasian / mixed race showed much higher levels of CRP in the black South Afri-
cans [4].
The Kenyan study was undertaken to explore sources of variation of RVs, to derive country
specific RIs and to standardize the RIs by use of a value-assigned panel of sera [4] intended for
nationwide use and international comparison.
Materials and methods
The methodology used in recruiting participants for the study, sample collection, handling
and analysis has previously been published [5]. The study was approved by the Aga Khan Uni-
versity Hospital Nairobi (2014/REC-46) and Stellenbosch University (S16/10/219) Health
Research Ethics Committees. The study was conducted in conformity with the Declaration of
Helsinki.
Study population
Recruitment of study participants in Kenya was carried out between January and October
2015 in several counties. Majority were urban dwellers from the capital city Nairobi, Kiambu
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county in central Kenya, Kisii County in western Kenya, and Nakuru County based in the
Great Rift Valley.
Inclusion and exclusion criteria
Inclusion of participants was limited to healthy adults aged 18–65 years stratified into 4 age
groups: 18–29, 30–39, 40–49 and 50–65 years. Exclusion criteria included individuals with a
body mass index (BMI) >35 kg/m2, consumption of ethanol�70 g per day, smoking >20 cig-
arettes per day, taking regular medication for a chronic disease (diabetes mellitus, hyperten-
sion, hyperlipidemia, allergic disorders, depression), recent (< 15 days) recovery from acute
illness, injury or surgery requiring hospitalization, carrier of HBV, HCV or HIV, pregnant or
within 1 year after delivery. Written informed consent was obtained after written/verbal
explanation of the study. Those with any chronic disease were excluded except for individuals
aged 50–65 years who had well controlled hypertension taking up to 2 drugs. A single mea-
surement of blood pressure, abdominal circumference and BMI was done after filling the
study questionnaire.
Blood collection and handling
Blood samples were collected by trained phlebotomists into a serum separator tube for all ana-
lytes tested in serum, lithium heparin tube for troponin I, sodium fluoride tube for plasma glu-
cose. Serum and plasma samples requiring centrifugation were spun 2–4 hours after collection
and stored at −80˚C at the Aga Khan University Hospital, Nairobi (AKUHN). Centrifugation
was done at 2000g, for 10 mins in a non-refrigerated centrifuge (Beckman coulter, Allegra X-
30, Brea, California, US) These were subsequently shipped frozen to the PathCare reference
laboratory in Cape Town, South Africa for analysis. We also drew 2mL of whole blood for test-
ing hematology parameters using Beckman-Coulter ACT5-DIFF-CP analyser (Brea, Califor-
nia, US), tested in PathCare Nairobi. The test results were primarily used for establishing RIs
for hematology parameters [5], but they were referred to in this study for secondary exclusion
of individuals with latent anemia or inflammation.
Measurements
The analysis of all serum specimens was performed in batches on the Beckman Coulter AU
5800 (Brea, California, US) for chemistry assays and DXI (Brea, California, US) for immunoas-
says as summarized in Table 1.
Quality control
The PathCare reference laboratory is accredited by the South African National Accreditation
System. For purposes of the global RI study, all participating laboratories received a panel of
sera produced by the C-RIDL in 2014 that had assigned values [4]. This panel was measured
by participating laboratories to enable recalibration of RVs using linear regression analysis. It
also allowed for alignment of RVs across different countries by all-pairwise comparison of test
results.
Statistical analysis
In order to assess sex, age and BMI as sources of variation, we adopted the standard deviation
ratio (SDR), which represents a ratio of between-subgroup SD (variation of the subgroup
means from grand mean) to between-individual SD (approximately 0.25 the width of RI). For
calculating SDRs, we first performed 2-level nested ANOVA to compute between-sex SD and
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between-age SD after partitioning age at 30, 40, and 50 years. With the results, the SDR for
between-sex SD (SDRsex) and between-age SD (SDRage) were calculated as a ratio to the
residual SD that corresponds to roughly between-individual SD or SD comprizing RI (SDRI.
Since between-age variation changes by sex, we also computed SDRage for each sex by one
way ANOVA. We considered SDR�0.40 as a primary criterion for judging the need for parti-
tioning RVs by sex and/or age [5].
Table 1. Summary of tests, equipment, assay methods and analytical performance.
Analyte Abbreviation Method Units Between Run CV
Sodium Na Ion selective electrode / diluted (indirect) mmol/L 1.3
Potassium K Ion selective electrode / diluted (indirect) mmol/L 3.8
Chloride Cl Ion selective electrode / diluted (indirect) mmol/L 1.4
Urea Urea Urease mmol/L 2.4
Creatinine Cre Modified kinetic Jaffè μmol/L 1.6
Total Protein TP Biuret g/L 4.6
Albumin Alb Bromocresol Green dye binding g/L 2.8
Total Bilirubin TBil Diazonium salt μmol/L 7.7
Gamma-glutamyl transferase GGT Gamma-glutamyl-3-carboxy-4-nitroanilide IU/L 3.3
Alkaline phosphatase ALP P-nitro-phenylphosphate hydrolysis IU/L 4.0
Lactate dehydrogenase LDH Lactate to Pyruvate IU/L 3.2
Calcium Ca Arsenazo III dye mmol/L 1.4
Magnesium Mg Xylidyl blue mmol/L 1.9
Phosphate IP Molybdate hydolysis mmol/L 1.8
Lipase Lip 1, 2-Diglyceride hydrolysis U/L 8.0
Total cholesterol TC Cholesterol oxidase mmol/L 1.2
Triglycerides TG Glycerol phosphate oxidase mmol/L 4.1
High density lipoprotein cholesterol HDL-C Two phase selective accelerator detergent mmol/L 2.0
Low density lipoprotein cholesterol LDL-C Two phase selective accelerator detergent mmol/L 1.6
Uric acid UA Modified Trinder reaction with Uricase mmol/L 1.2
High sensitive c reactive protein CRP Turbidimetry mg/L 1.8
Amylase AMY 2-chloro-4-nitrophenyl-α-D-maltotrioside U/L 8.1
Immunoglobulin A IgA Turbidimetry g/L 1.3
Immunoglobulin G IgG Turbidimetry g/L 1.1
Immunoglobulin M IgM Turbidimetry g/L 7.0
Alanine aminotransferase ALT NADH (without P-50-P) U/L 28.1
Aspartate aminotransferase AST NADH (without P-50-P) U/L 5.6
Creatinine kinase CK Creatine phosphate dephosphorilysation U/L 6.5
Iron Fe 2, 4, 6-Tri-(2-pyridyl)-5-triazine chromogen μmol/L 4.2
Transferrin Tf Turbidimetry g/L 2.6
Anti-thyroglobulin TgAb Two-site immune—enzymatic immunoassay IU/ml 4.8
Anti-thyroid peroxidase TPOAb Two-site immune—enzymatic immunoassay IU/ml 28.8
Thyroid stimulating hormone TSH Two-site immune—enzymatic immunoassay mIU/L 13.0
Free thyroxine FT4 Two-site immune—enzymatic immunoassay pmol/L 8.1
Free tri-iodothyronine FT3 Two-site immune—enzymatic immunoassay pmol/L 4.8
Ferritin Fer Turbidimetry μg/L 8.2
Prostate specific antigen PSA Two-site immune—enzymatic immunoassay μg/L 2.3
As calculated parameters, globulin (Glb) was computed as TP—Alb; non-HDL-C as TC—HDL-C; HDL-C ratio (HDLrat) as TC/HDL-C.
https://doi.org/10.1371/journal.pone.0235234.t001
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However, SDR represents between-subgroup difference at the center of the RV distribution,
which may not reflect the difference (bias) at LL or UL (ΔLL or ΔUL). Therefore, we also evalu-
ated ΔLL or ΔUL as its ratio to SD comprising RI (SDRI) [= |UL−LL|/3.92] and expressed it as
bias ratio (BR) at LL or UL (BRLL or BRUL). For example, the formula for determining BR for
sex was:
BRLL ¼
jLLM   LLFj
ðULMF   LLMFÞ=3:92
; BRUL ¼
jULM   ULFj
ðULMF   LLMFÞ=3:92
where subscripts of MF, M, and F attached to LL or UL indicate the RI without partition by
sex (for male+female) and the RIs after partition by male and female, respectively [6]. The
same calculation was done for judging the need for age-specific RIs by setting LL, UL with/
without partitioning by age. The distinction of the concepts between SDR and BR is illustrated
in Fig 1.
In setting the threshold for the bias ratios, we followed the convention of allowable limits of
bias in measurements:
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SD2I þ SD2G
p
� 0:375, where SDI and SDG represent within-individual
and between-individual SD [7]. Since SDRI or the denominator of BR is composed of both SDI
and SDG and equal to
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SD2I þ SD2G
p
, we set 0.375 as a threshold for BR. This scheme was
adopted in recent papers [8,9]. On the other hand, both SDR and BR depend on their common
Fig 1. SD ratio (SDR) vs. bias ratio (BR) as a measure of between-subgroup differences. SDR represents between-subgroup differences at the center of
distributions, while BR represents between-subgroup differences at the periphery (LL or UL) of the distributions. The numerator of SDR is between-subgroup SD
(or SDsex, if sub-grouped by sex), while that of BR is a difference of LLs or ULs.
https://doi.org/10.1371/journal.pone.0235234.g001
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denominator, SDRI. For example, when the RI is narrow, both ratios can be inflated. Con-
versely, when the RI is wide, both ratios are suppressed. In order to cope with such situations,
we set a pragmatic third criterion that between-subgroup bias at LL or UL (ΔLL or ΔUL)
should be equal to or more than 3 times the “reporting unit (RU)” to allow partitioning of
RVs. RU represents a unit of value for reporting test results. If the number of digits below the
decimal point in reporting test results is 2, 1, or 0, RU is 0.01, 0.1, or 1, respectively. The flow
of logic in deciding the need for partitioning by sex or age is shown in Fig 2.
RIs were determined using both parametric and non-parametric methods before and after
applying the latent abnormal values exclusion (LAVE) method [10,11]. For the non-paramet-
ric method, the RVs coinciding with the 2.5th and 97.5th percentiles after sorting the data in
ascending order were used as the lower and upper limits (LL, UL) of the RI. For the parametric
method, the RVs were transformed into a Gaussian form by the Box-Cox power transforma-
tion formula, and then mean±1.96 SD was computed as the central 95% limits (LL−UL) under
the transformed scale, which were then reverse transformed to get the LL and UL in the origi-
nal scale [11].
As a measure for secondary exclusion of abnormal values, we tried to apply LAVE in deriv-
ing the RI both by parametric and nonparametric methods [11]. For LAVE, we primarily used
the following set of reference tests: Alb, Glb, UA, Glu, non-HDL, TG, ALT, AST, LDH, CK,
Fig 2. Scheme for partitioning RVs by sex and age. We adopted this flow-chart in judging the needs for partitioning RVs by sex and age. We defined
between-sex (or -age) subgroup bias in reference to the three points: 1) SDR>0.4 that represents the between-subgroup bias at the center of RV
distribution, 2) BR>0.375 that represents the between-subgroup bias at the limits (LL or UL) of RV distribution, and 3) the actual difference (bias)�
three reporting unit (RP). There were eight possible choices for the partitioning.
https://doi.org/10.1371/journal.pone.0235234.g002
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GGT, and CRP, which were meant for excluding individuals with inappropriate values in the
nutritional, inflammatory, or muscular damage markers. As an exception, for iron related ana-
lytes (Fe, Ferr, Tf, and TfSat), we set hemoglobin (Hb), hematocrit (Hct), and mid-corpuscular
volume (MCV) in addition to the four iron markers as the reference tests. For proteins (TP,
Alb, Glb, IgG/A/M, CRP), we set all the seven tests plus white blood cell and platelet counts as
the reference tests.
On the other hand, for determination of RIs for the thyroid panel, the LAVE procedure was
not applied because reference tests associated with the thyroid panel were not available. Rather,
we first estimated the cutoff values for anti-thyroglobulin antibody (TgAb), and anti-thyroid
peroxidase antibody (TPOAb) from the probability paper plot drawn with x-axis in logarith-
mic scale, as an intersection of the central linear part with the horizontal line at 97.5 percentile
as shown in Fig 3.
For judging the need for adopting LAVE, we computed BRLL and BRUL by setting LLs and
ULs of RIs with/without LAVE: i.e., SDRI in the denominator was set to the RI by the LAVE
procedure. The 90% confidence intervals (CIs) of LL and UL were derived by the bootstrap
method with resampling of the final set of RVs and repeated computations of LL and UL for
50 iterations. Accordingly, final RIs were determined as the averages of LL and UL thus
derived.
Results
Profile of the subjects
Out of 596 volunteers, 533 met the inclusion criteria: 260 (48.8%) males and 273 (51.2%)
females. The main reason for exclusion was hypertension as shown in Fig 4.
The median age was 39 years with a range of 18–65 years. The participant characteristics
are summarized in Table 2.
Sources of variation
Sex, age and BMI as sources of variation were explored with SDR�0.4 regarded as being signif-
icant as shown in Table 3.
Between-sex differences exceeded that level in Alb, UA, Cre, TBil, Cl, ALT, AST, CK, GGT,
Ferr, Tf, TfSat, and IgM. Similarly, between-age subgroup differences were significant for Alb,
Cl, Glu, and TG in males, and for Alb, urea, Na, Mg, Glu, TC, TG, HDLrat, LDL-C, ALT, ALP,
and Ferr in females. BMI was an independent source of variation for UA, Glu, TC, HDLrat,
nonHDL-C, LDL-C, ALT, AST, LDH, and GGT in males, and for CRP only in females. Graph-
ical representations of reference value distribution sub-grouped by sex and age are shown for
12 representative analytes in Fig 5 and for all analytes in S1 Fig.
Reference intervals
Generally, the parametric method resulted in similar or lower RI ULs, and narrower 90% CIs
for the LL and UL of the RIs compared to the non-parametric method as shown in S2 Fig.
Besides, the accuracy of Gaussian transformation by the parametric method was confirmed as
shown in S3 Fig. Therefore, we adopted the RIs derived by the parametric method exclusively.
In addition, we could not calculate a RI for Trop I because 94.7% of RVs were below detection
limit. For TgAb and TPOAb, we determined cutoff values by use of the probability paper plot
as 2.5 IU/ml and 5.0 IU/mL respectively as shown in Fig 3. We regarded individuals who had
antibody values exceeding either of the cutoffs (7.7% of males and 13.6% of females) as possible
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autoimmune thyroiditis (AIT), and excluded them when calculating RIs for thyroid function
tests.
The LAVE method resulted in significant differences in LL or UL (BRUL or BRLL > 0.375)
for some analytes as shown in S1 Table. For example, UL lowered for AST, ALT, CRP; LL
raised for Fe.
Based on the decision flow chart shown in Fig 2, RIs for TP, Alb, Glb, Na, K, Cl, Ca, IP, Glu,
TG, HDL-C, nonHDL, Lip, AMY, LDH, CRP, Fe, IgG and IgA were not partitioned by sex as
shown in Table 4. For age partitions, although the mean age of menopause for females is about
50 years, we chose 45 years as the borderline because there were limited number of subjects
above the age of 50.
A comparison of our RIs with those recommended by Beckman coulter and those derived
from IFCC studies conducted in India, Saudi Arabia and Turkey found much higher RIs for
TBil as shown in Table 5. A similar comparison that also includes studies carried out in other
African countries is shown in S2 Table.
Standardization of the RIs
Since this study utilized a serum panel provided by C-RIDL which comprised 50 samples with
values assigned to 25 chemistry analytes, we confirmed the standardized status of the assays as
Fig 3. Determination of cutoff values for TgAb and TPOAb based on the probability paper plot. Cutoff values for thyroglobulin antibody (TgAb), and thyroid
peroxidase antibody (TPOAb) were empirically determined by use of the probability paper plot. Y-axis represents cumulative frequencies of RV distribution, while
x-axis was drawn in logarithmic scale. We assumed that both antibodies are specific to autoimmune thyroiditis (AIT), and thus extreme values in the tail
constitutes a group of values from AIT cases. Therefore, we determined the cutoff value as an intersection of central linear part with the horizontal line at 97.5%.
https://doi.org/10.1371/journal.pone.0235234.g003
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shown in S4 Fig. For the method comparison, major-axis regression was used to express the
structural relationship between our test results and the panel assigned values by calculating
BRLL or BRUL as a difference of LL or UL before and after the recalibration using the regression
coefficients. As a result, we found it necessary to recalibrate our RIs for HDL-C and LDH. For
Na, we could not get a good linear relationship because of poor precision of the assay with the
narrow reference interval.
Discussion
There have been controversies over the statistical methods used in deriving RIs. They include:
selection between parametric and nonparametric methods, how and when to exclude RVs sec-
ondarily, and when to partition RVs into subgroups by sex and age. In this study we sought
Fig 4. Study flowchart. BMI: body mass index, CBC: complete blood count, DM: diabetes mellitus, HIV: Human
Immunodeficiency Virus, HTN: hypertension. �On antibiotics, blood donation in past 3 months, on treatment for
hypothyroidism,> 65 years,> 65 years and hypertensive, rheumatic heart disease, prostate cancer.
https://doi.org/10.1371/journal.pone.0235234.g004
Table 2. Descriptive characteristics of participants.
Male (n = 260) Female (n = 273) Total (n = 533)
Median (IQR) Min-Max Median (IQR) Min-Max Median (IQR) Min-Max
Age (years) 39 (18) 20–65 39 (21) 18–64 39 (20) 18–65
Height (cms) 172 (8) 156–191 160 (9) 143–191 167 (13) 143–191
Weight (kg) 74 (19) 46–116 68 (16) 38–109 70 (18) 38–116
BMI (kg/m2) 24.9 (5.6) 16.3–34.9 26.1 (6.3) 17.1–38.1 25.5 (5.9) 16.3–38.1
BSA (m2) 1.88 (0.24) 1.44–2.36 1.72 (0.20) 1.27–2.24 1.78 (0.22) 1.27–2.36
AC (cm) 91 (15) 65–124 86 (16) 64–115 89 (17) 64–124
BP Systolic (mmHg) 127 (18) 84–179 128 (18) 118 (20) 124 (21) 77–194
BP Diastolic (mmHg) 81 (12) 56–101 79 (14) 57–112 80 (14) 56–112
AC: abdominal circumference; BMI: body mass index; BSA: body surface area; IQR: interquartile range
https://doi.org/10.1371/journal.pone.0235234.t002
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optimal options for each. We found the nonparametric method of limited use with its wider
90% CI for RIs and frequent bias in UL (S1 Fig), while the parametric method was found to be
more reliable after successful Gaussian transformation (S3 Fig). For secondary exclusion, we
found LAVE procedure effective for reducing the influence of over nutrition for those analytes
with high association with BMI such as TG, ALT, AST, and CRP. It was also effective in reduc-
ing the influence of latent inflammation and anemia on Fe, Tf and TfSat.
In order to decide the need for partitioning RVs into subgroups by sex or age, we primarily
used SDR, but it tended to provide an inflated value when the width of the RI was narrow.
Another problem of SDR is that it reflects between-subgroup difference at the central part
which may not reflect between-subgroup bias at the LL or UL, hence the use of BRLL or BRUL.
Furthermore, we found it necessary to confirm the appropriateness of BRLL or BRUL by quanti-
tating the actual difference at LL or UL by use of the reporting unit (RU). We chose to adopt
partitioned RIs only when the difference at LL or UL was�3RU. We believe this three-way
consideration ensured optimal judgement in partitioning RIs by sex and age as shown in S1
Table.
RIs can vary appreciably across different populations as demonstrated in the interim report
of the global study analyzing RVs of 12 countries [4]. They identified ethnic differences in
many analytes such as Alb, urea, TBil, HDL-C, CRP, IgG, C3, and PTH. In reference to the RV
profiles, we noted certain unique features of Kenyan RIs. For instance, our urea RIs are lower
than those from Turkey and Saudi Arabia. Although most of our RIs for liver function tests
Table 3. Standard deviation ratios for between sex and age.
SDRsex SDRage SDRsex SDRage
M+F M+F M F M+F M+F M F
TP 0.00 0.36 0.38 0.35 ALT 0.56 0.42 0.31 0.52
Alb 0.50 0.54 0.56 0.53 AST 0.48 0.26 0.09 0.34
Glb 0.32 0.00 0.00 0.00 ALP 0.00 0.47 0.16 0.66
Urea 0.30 0.32 0.21 0.42 AMY 0.05 0.00 0.00 0.00
eGFR 0.00 0.32 0.34 0.29 LDH 0.00 0.22 0.00 0.31
UA 0.89 0.38 0.41 0.33 CK 0.50 0.08 0.02 0.12
Cre 1.19 0.24 0.30 0.14 GGT 0.51 0.28 0.35 0.14
TBil 0.48 0.27 0.21 0.32 Iron 0.39 0.09 0.10 0.08
Na 0.00 0.38 0.14 0.47 Ferr 0.78 0.26 0.22 0.45
K 0.00 0.23 0.22 0.25 TF 0.43 0.18 0.18 0.18
Cl 0.44 0.30 0.38 0.18 TFSat 0.50 0.00 0.00 0.00
Ca 0.16 0.29 0.31 0.26 CRP 0.10 0.31 0.37 0.25
IP 0.21 0.20 0.22 0.17 IgA 0.00 0.24 0.15 0.31
Mg 0.00 0.46 0.38 0.52 IgG 0.10 0.12 0.17 0.07
Glu 0.00 0.41 0.44 0.39 IgM 0.48 0.12 0.15 0.08
TC 0.00 0.41 0.41 0.42 FT3 0.12 0.04 0.00 0.09
TG 0.22 0.58 0.56 0.60 FT4 0.00 0.36 0.35 0.37
HDL-C 0.33 0.00 0.00 0.00 TSH 0.00 0.00 0.00 0.03
HDLrat 0.33 0.38 0.39 0.37 TgAb 0.00 0.28 0.27 0.28
nonHDL 0.00 0.45 0.44 0.46 TPOAb 0.09 0.04 0.06 0.03
LDL-C 0.00 0.42 0.40 0.43 Trop I 0.00 0.08 0.00 0.09
Lip 0.07 0.16 0.17 0.15 PSA 0.39
SDR�0.4 shown in bold; SDR�0.5 orange background
https://doi.org/10.1371/journal.pone.0235234.t003
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Fig 5. Sex and age-related changes for 12 analytes. The distributions of reference values are shown based on age and sex
stratification for 12 analytes. The SDRsex and SDRage for each sex are shown at the top of each analyte chart. No secondary
exclusion was performed in plotting the data. The box in each scattergram represents central 50% range and the vertical bar in the
middle represents a median point.
https://doi.org/10.1371/journal.pone.0235234.g005
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Table 4. Proposed reference intervals.
M + F M F
Item Units Age n LL UL n LL UL n LL UL
TP g/L All 526 67 83
Alb g/L ~45 349 39 50
45~ 150 39 47
Glb g/L All 524 24 38
Urea mmol/L All 258 2.4 6.6
~45 145 1.8 5.2
45~ 83 1.8 6.4
UA mmol/L All 259 238 532 272 178 417
Cre μmol/L All 260 58 109 271 45 86
TBil μmol/L All 257 6 43 271 5 27
Na mmol/L All 531 134 142
K mmol/L All 531 3.4 4.8
Cl mmol/L All 501 100 110
Ca mmol/L All 531 2.19 2.57
IP mmol/L All 533 0.78 1.42
Mg mmol/L All 260 0.73 0.98
~45 174 0.71 0.93
45~ 99 0.76 1.01
Glu mmol/L ~45 345 3.9 5.8
45~ 172 4.4 7.3
TC mmol/L All 260 3.1 6.9
~45 174 3.1 6.2
45~ 99 3.2 7.1
TG mmol/L ~45 289 0.47 2.60
45~ 154 0.55 3.70
HDL-C mmol/L All 530 0.7 1.7
HDLrat All 259 2.6 7.6
~45 174 2.4 5.9
45~ 98 2.7 6.7
nonHDL mmol/L All 532 2.0 5.6
LDL-C mmol/L All 260 1.6 4.8
~45 174 1.5 4.2
45~ 99 1.7 4.9
Lip U/L All 527 9 68
ALT IU/L All 202 10 55 229 7 30
AST IU/L All 206 17 40 227 15 29
ALP IU/L All 260 53 153
~45 172 47 130
45~ 99 55 174
AMY IU/L All 530 47 164
LDH IU/L All 530 138 257
CK IU/L All 259 72 460 268 53 260
GGT IU/L All 199 13 90 269 10 50
CRP mg/L All 425 0.21 14.67
Fe μmol/L All 412 8.8 28.9
(Continued)
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were similar to published reports from Saudi Arabia and Turkey [12,13], our TBil RI of 6–-
43 μmol/L for males and 5–27 μmol/L for females is almost double what has been reported in
published studies from outside the African continent as shown in S2 Table [2,12–15]. We
hypothesize that Gilbert’s syndrome, the commonest genetic cause of asymptomatic unconju-
gated hyperbilirubinaemia, could be quite prevalent in our population. Genetic studies would
thus be useful in elucidating the cause of hyperbilirubinaemia observed in our study.
Our electrolytes didn’t differ much from other published IFCC studies except that Mg levels
increased with age in females. It has been documented that reduced levels of oestrogen are
associated with increased Mg levels in post-menopausal women as well as in the follicular
phase of the menstrual cycle in women of reproductive age [16,17].
Our TC and TG RIs were higher than those reported by Kibaya et al who carried out a simi-
lar study in a rural Kenyan population [18]. Our study population was primarily composed of
urban dwellers of whom 25.6% had metabolic syndrome [19]. According to the third report of
the National Cholesterol Education Program (NCEP), the desirable LDL-C level for low risk
adults is <4.1 mmol/L [20]. Our UL for LDL-C in males (4.8 mmol/L) and in females (4.2 and
4.9 mmol/L) are higher than the NCEP targets. However, the NCEP clinical decision limits
(CDLs) are used for diagnosis of hyperlipidaemia and serve as treatment targets for reducing
cardiovascular risk. Aside from the risk of over-nutrition, the RI ULs for TC and LDL-C are
important in diagnosing cholestatic conditions and hypothyroidism. These are relatively
short-term conditions unrelated to occurrence of atherosclerosis hence the RIs are more rele-
vant than CDLs in their diagnosis. On the other hand, determination of LLs for TC or LDL-C
RIs are essential for diagnosing malnutrition or thyrotoxicosis. Therefore, we are not replacing
the derived RIs with those CDLs, rather providing CDLs in the footnote of test result report
sheet.
We obtained fasting plasma glucose (FPG) RIs of 3.9−5.8 and 4.4−7.3 mmol/L for those
aged<45 and�45 years respectively. The former RI is comparable to what was obtained in
Turkey (3.96−5.88 mmol/L) and Saudi Arabia (4.0−5.9 mmol/L) [12,13]. The American Dia-
betes Association (ADA) uses FPG� 5.6 and 7.0 mmol/L to define pre-diabetes and diabetes
respectively. Based on the ADA criteria, a total of 63 out of 528 participants would have been
classified as having elevated values compared to 20 if the ULs of the derived RIs were used.
Our RIs for immunoglobulins are higher than those derived in the US but very similar to
those derived in India [2,15]. Karita et al also found high levels of IgG in several SSA countries
Table 4. (Continued)
M + F M F
Item Units Age n LL UL n LL UL n LL UL
Ferr μg/L All 253 10 475
~45 173 2 150
45~ 99 0 222
Tf g/L All 254 1.9 3.2 206 2.0 3.5
TfSat % All 208 15 49 211 10 44
IgG g/L All 525 11.1 20.0
IgA g/L All 526 1.05 4.63
IgM g/L All 254 0.38 2.29 272 0.51 2.77
FT3 pmol/L All 467 3.9 6.3
FT4 pmol/L All 468 7.8 14.1
TSH mIU/L All 461 0.61 4.86
PSA μg/L All 243 0.29 2.92
https://doi.org/10.1371/journal.pone.0235234.t004
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[21]. We hypothesize that this may be due to inflammation caused by increased exposure to
either infectious disease agents or environmental allergens. The increased inflammation is fur-
ther evidenced by the very high RI UL for CRP of 14.7 mg/L compared to 1 mg/L recom-
mended by Beckman Coulter [22]. Ichihara et al in a similar study carried out in Asia found
that the closer the country or region was to the equator, the higher the serum concentrations
of positive inflammatory markers (IgG, C3, CRP) a phenomenon they ascribed to increased
exposure to infectious agents [23]. Similar to the IFCC study in India, IgM was significantly
higher in female participants requiring the determination of sex specific RIs [15]. We hypothe-
size that this could be linked to the role that estrogen plays in enhancing humoral immunity
[24].
Ichihara et al has demonstrated that BMI is a major source of variation in RVs for many
analytes and that the magnitude of this association varies across different populations [25]. For
example, a similar change in BMI resulted in a greater decline in HDL cholesterol amongst the
Japanese (r = −0.39) compared to people from Pakistan (r = −0.05). On the other hand, an
increase in BMI was associated with a greater increase in ALT values (r = 0.48) amongst non-
black South Africans compared to black South Africans (r = 0.02) [25]. BMI was a source of
variation for several analytes in males especially those known to be associated with the pres-
ence of metabolic syndrome such as Glu, LDL-C, and ALT. We did not partition our RIs by
BMI because the influence of BMI was suppressed by use of the LAVE method.
For iron markers, we also applied LAVE to reduce the influence of latent anemia. Although
it was very effective in raising their LLs, the female LL for ferritin was still lower than the
WHO cutoff value of<15 μg/L for iron deficiency [26].
The strengths of our study include the deliberate recruitment of healthy individuals using a
harmonized protocol to ensure pre-analytical confounders were minimized, centralized analy-
sis of samples in an accredited laboratory with excellent internal quality control, standardiza-
tion of the RIs by use of a value-assigned panel of sera and use of the LAVE procedure to
reduce the influence of sub-clinical disease on the derived RIs.
The weaknesses include failure to perform infectious serology to rule out chronic infections
such as HIV, HBV or HCV, and over representation of an urban population hence limiting
the generalizability of our findings to a rural population.
Conclusion
According to the harmonized IFCC-C-RIDL protocol, we established RIs for 40 major chemis-
try and immunoassay tests from well-defined healthy Kenyan volunteers by use of the up-to-
date statistical methods for the first time in Africa. The LAVE method was effective in reducing
the influence on RIs of latent anemia and metabolic disorders. Based on SD ratio and bias
ratios, we developed a flow chart to judge the need for partitioning RVs by sex and age sub-
groups, which we believe is helpful for the future RI study. RIs for chemistry analytes were
standardized by use of a value assigned serum panel, and thus could be shared across sub-
Saharan African laboratories with similar ethnic and life-style profile. As a whole, Kenyan RIs
were comparable to those of other countries participating in the global study with a few excep-
tions such as higher ULs for TBil and CRP.
Supporting information
S1 Fig. Sex and age-related changes. The distributions of reference values are shown based on
age and sex stratification for all analytes. The SDRsex and SDRage for each sex are shown at
the top of each analyte chart. No secondary exclusion was performed in plotting the data. The
box in each scattergram represents central 50% range and the vertical bar in the middle
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represents a median point.
(PDF)
S2 Fig. Bar-chart comparison of reference interval calculation methods. The RIs of all ana-
lytes were derived in four ways by parametric (P) or nonparametric (NP) method with/without
the LAVE procedure, separately in males+Females (MF), males, and females. Each horizontal
bar represents the range of the RI, and the vertical line in the center corresponds to the mid-
point. The shades on both ends of the bar represent 90%CI for the limits of the RI predicted by
the bootstrap method.
(PDF)
S3 Fig. Results of Gaussian transformation by the parametric method. The accuracy of
Gaussian transformation by Box-Cox formula can be assessed from theoretical Gaussian
curves in two histograms shown on left top (before and after the transformation) of each
panel. Accuracy can be also seen from the linearity in probability paper plot on the right. The
limits of the RI by nonparametric method corresponds to the points where red zigzag line
intersect with horizontal 2.5 and 97.5% red lines of cumulative frequencies.
(PDF)
S4 Fig. Panel test results for assessment of standardized status of assays. The panel of sera
from 50 healthy volunteers, each of which were value assigned for 40 chemistry analytes were
measured. Our measured values were plotted on Y-axis and assigned values on X-axis. Major
axis linear regression was used as a structural relationship for the method comparison. The
Y = X line is shown as a diagonal broken line.
(PDF)
S1 Table. Reference intervals and determination of method, sex and age bias.
(PDF)
S2 Table. Comparison of reference intervals.
(PDF)
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